About Aragen Bioscience
Aragen Bioscience is a company based in Morgan Hill (United States) founded in 1993 was acquired by Aragen in January 2014. Aragen Bioscience offers products and services including Cell Line Development, Protein Expression, Analytical Services, and Preclinical Efficacy Testing. Aragen Bioscience operates in a competitive market with competitors including Evotec, Crown Bioscience, Alloy Therapeutics, CatSci and NIH, among others.
- Headquarter Morgan Hill, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Goldman Sachs
& 3 more
-
Employee Count
Not available
-
Acquired by
Aragen
(Jan 29, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aragen Bioscience
Aragen Bioscience offers a comprehensive portfolio of products and services, including Cell Line Development, Protein Expression, Analytical Services, and Preclinical Efficacy Testing.
Service for developing stable cell lines for biopharmaceutical research.
Process for expressing and purifying proteins for therapeutic applications.
Laboratory services for analyzing biologics quality and efficacy.
Testing protocols for evaluating drug candidates in animal models.
Funding Insights of Aragen Bioscience
Investors in Aragen Bioscience
Aragen Bioscience has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Goldman Sachs, Aragen Life Sciences and Oxford University Innovation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment banking services are delivered across multiple financial sectors.
|
Locked | Locked | Locked | |
|
Investment management services for science ventures are provided in Oxford.
|
Locked | Locked | Locked | |
|
Startups are incubated by Oxford University Innovation.
|
Locked | Locked | Locked |
Investor details for Aragen Bioscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aragen Bioscience
Investment portfolio details for Aragen Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aragen Bioscience
Detailed financials for Aragen Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aragen Bioscience Comparisons
Peer comparison for Aragen Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aragen Bioscience
Aragen Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evotec, Crown Bioscience, Alloy Therapeutics, CatSci and NIH, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug discovery and development services are provided to biopharma sector.
|
|
| Locked | Locked | Locked |
Cancer and CVMD drugs are developed using PDX models.
|
|
| Locked | Locked | Locked |
Drug discovery services are provided for therapeutic development.
|
|
| Locked | Locked | Locked |
Drug discovery services are provided to pharmaceutical clients worldwide.
|
|
| Locked | Locked | Locked |
Drug discovery services are provided to the biopharma sector.
|
|
| Locked | Locked | Locked |
Drug discovery CRO company for epigenetic research and inflammatory diseases
|
Detailed competitors of Aragen Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aragen Bioscience
Complete news archive for Aragen Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aragen Bioscience
Aragen Bioscience was founded in 1993 and raised its 1st funding round 25 years after it was founded.
Aragen Bioscience is headquartered in Morgan Hill, United States. It is registered at Morgan Hill, California, United States.
Aragen Bioscience was established in 1993 as a contract research organization based in Morgan Hill, United States. Operations focus on the biotech and pharmaceutical sectors, with services encompassing cell line development, protein expression and purification, molecular biology, immunology, and both in vitro and in vivo efficacy assessments for biologic and diagnostic products. Early development support is extended through these integrated capabilities.
Aragen Bioscience's top competitors include Evotec, Crown Bioscience and NIH.
Aragen Bioscience offers Cell Line Development, Protein Expression, Analytical Services, and Preclinical Efficacy Testing.
Aragen Bioscience has 4 investors. Key investors include Goldman Sachs, Aragen Life Sciences, Oxford University Innovation, and Oxford Science Enterprises.